GW PHARMA

GW Pharma focuses on the development and commercialization of innovative drugs for indications in the mental area (CNS), and hopes to provide faster, more effective and safer treatments for unmet needs in the clinical antidepressant field. drug. The team members have rich experience in CNS new drug research and development, and product pipelines are arranged around depression and anxiety. The current data of the company's core products proves that it has obvious safety advantages compared with the products already on the market.